Literature DB >> 7470760

Prejunctional actions of piribedil on the isolated kidney of the rabbit: comparison with apomorphine.

C Chevillard, M N Mathieu, D Recommis.   

Abstract

1 The effects of piribedil on contractile responses and noradrenaline release evoked by sympathetic nerve stimulation have been studied in the isolated kidney of the rabbit. These effects were compared to those of apomorphine.2 Electrical stimulation (2, 5 and 10 Hz) of sympathetic renal nerves produced frequency-dependent increases in perfusion pressure and noradrenaline release. Piribedil did not affect (0.1 mug/min) or diminished (1 and 10 mug/min) the stimulation-evoked increase in perfusion pressure, and increased noradrenaline release in a dose-dependent manner.3 Increases in renal perfusion pressure and noradrenaline release induced by electrical stimulation were decreased by apomorphine (0.1 and 1 mug/min). These inhibitory effects were more marked at low frequencies of stimulation and were prevented by haloperidol (0.2 mumol/1).4 Piribedil (0.1 and 1 mug/min) and apomorphine (0.1, 1 and 10 mug/min) did not affect the increases in renal perfusion pressure elicited by exogenously administered noradrenaline, but piribedil (10 mug/min) diminished them.5 In the presence of desipramine (0.5 mumol/l), piribedil (0.1, 1 and 10 mug/min) produced a dosedependent inhibition of the increases in renal perfusion pressure and noradrenaline release evoked by sympathetic nerve stimulation; the inhibitory effect of piribedil was more marked at low frequencies of stimulation and was prevented by haloperidol.6 Piribedil increased the resting release of noradrenaline from the rabbit kidney, in contrast to apomorphine, which was without effect.7 It is suggested that piribedil has a complex effect on sympathetic transmission. This drug exhibits an ;amphetamine-like' action, causing noradrenaline release from its postganglionic stores. This releasing effect masks an action on prejunctional inhibitory dopamine receptors. In addition, at high doses, piribedil exhibits a marked action on postjunctional sites, since it reduces the vasoconstrictor effect of exogenous noradrenaline.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7470760      PMCID: PMC2044437          DOI: 10.1111/j.1476-5381.1980.tb10965.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  Isolation and radioenzymic estimation of picogram quantities of dopamine and norepinephrine in biological samples.

Authors:  C Gauchy; J P Tassin; J Glowinski; A Cheramy
Journal:  J Neurochem       Date:  1976-03       Impact factor: 5.372

2.  Dopamine receptors in the femoral vascular bed of the dog as mediators of a vasodilator and sympathoinhibitory effect.

Authors:  M Laubie; H Schmitt; E Falq
Journal:  Eur J Pharmacol       Date:  1977-04-07       Impact factor: 4.432

Review 3.  Local regulation of adrenergic neurotransmission.

Authors:  T C Westfall
Journal:  Physiol Rev       Date:  1977-10       Impact factor: 37.312

4.  Femoral vasodilatation produced by piribedil (ET495) and its metabolite S584 in the hindleg of the dog.

Authors:  W A Buylaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-08       Impact factor: 3.000

Review 5.  Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release.

Authors:  S Z Langer
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

6.  Presynaptic dopamine receptors as mediators of dopamine-induced inhibition of neurogenic vasoconstriction.

Authors:  M F Lokhandwala; J P Buckley
Journal:  Eur J Pharmacol       Date:  1977-10-01       Impact factor: 4.432

7.  Inhibitory effects of piribedil on adrenergic neurotransmission.

Authors:  M Laubie; H Schmitt
Journal:  Eur J Pharmacol       Date:  1978-11-01       Impact factor: 4.432

8.  Effects of piribedil on noradrenaline and MOPEG-SO4 levels in the rat brain.

Authors:  S Garattini; S R Bareggi; V Marc; G Calderini; P L Morselli
Journal:  Eur J Pharmacol       Date:  1974-09       Impact factor: 4.432

9.  ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors.

Authors:  H Corrodi; L O Farnebo; K Fuxe; B Hamberger; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1972-11       Impact factor: 4.432

10.  Apomorphine and piribedil in rats: biochemical and pharmacologic studies.

Authors:  R F Butterworth; J C Poignant; A Barbeau
Journal:  Adv Neurol       Date:  1975
View more
  2 in total

Review 1.  [Modulation of renal transmitter release by presynaptic receptors].

Authors:  L C Rump; P Schollmeyer
Journal:  Klin Wochenschr       Date:  1989-09-01

2.  Effects of the novel dopamine DA2-receptor agonist carmoxirole (EMD 45609) on noradrenergic and purinergic neurotransmission in rat isolated kidney.

Authors:  L C Rump; K Wilde; C Bohmann; P Schollmeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-03       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.